Aurora A 抗体
Quick Overview for Aurora A 抗体 (ABIN2477554)
抗原
See all Aurora A (AURKA) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
交叉反应
- 小鼠
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
亚型
- IgG2b
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
: "Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells." in: Haematologica, Vol. 98, Issue 10, pp. 1539-46, (2013) (PubMed).
: "Preparation and characterization of a human aurora-A kinase monoclonal antibody." in: Molecular and cellular biochemistry, Vol. 243, Issue 1-2, pp. 123-31, (2003) (PubMed).
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
-
- Aurora A (AURKA) (Aurora Kinase A (AURKA))
-
别名
- AURORA-A KINASE
-
背景
- Synonyms: SERINE/THREONINE KINASE 15
-
基因ID
- 6790
-
UniProt
- O14965
-
途径
- Cell Division Cycle, Asymmetric Protein Localization
抗原
-